Democratic VP candidate Bentsen
Executive SummaryAug. 15 letter from Bentsen's attending physician on the candidate's health includes a paragraph on the effect of recent treatment with Merck's Mevacor. Antonio Gotto, MD, reported that Bentsen was recommended to take a "a small dosage" of lovastatin (20 mg daily) beginning in April of this year to supplement a dietary effort to reduce a to reduce a cholesterol level of 245 mg/dl and an LDL value of 155 mg/dl. "Because of your schedule and difficulty in maintaining strict dietary adherence," Gotto told Bentsen, "we elected to begin a trial of a low dose of lovastatin . . . After approximately one month, the cholesterol was reduced to 200 mg/dl and LDL-cholesterol to 101 mg/dl." Gotto commented that "I am very pleased with this response"
You may also be interested in...
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.
Successfully acquired by Colgate-Palmolive on 31 January, Hello quickly made a statement with the launch of a CBD oral-care range and its first go at lip care, CBD Vegan Lip Balm. Available exclusively through Ulta Beauty, the CBD products have the potential to score well with younger consumers interested in natural ingredients, eco-friendly packaging and, of course, cannabis-based innovations.
A BLA filing for Zynteglo in beta-thalassemia is expected in the second half of 2020 instead of the first half, but the first commercial patient in the EU will be treated in the first half of this year.